Literature DB >> 32639610

Long-term outcomes of anterior cruciate ligament reconstruction surgery: 2020 OREF clinical research award paper.

Braden C Fleming1,2, Paul D Fadale1, Michael J Hulstyn1, Robert M Shalvoy1, Glenn A Tung1, Gary J Badger3.   

Abstract

ACL injuries place the knee at risk for post-traumatic osteoarthritis (PTOA) despite surgical anterior cruciate ligament (ACL) reconstruction. One parameter thought to affect PTOA risk is the initial graft tension. This randomized controlled trial (RCT) was designed to compare outcomes between two graft tensioning protocols that bracket the range commonly used. At 7 years postsurgery, we determined that most outcomes between the two tension groups were not significantly different, that they were inferior to an uninjured matched control group, and that PTOA was progressing in both groups relative to controls. The trial database was also leveraged to gain insight into mechanisms of PTOA following ACL injury. We determined that the inflammatory response at the time of injury undermines one of the joint's lubricating mechanisms. We learned that patients continue to protect their surgical knee 5 years postinjury compared to controls during a jump-pivot activity. We also established that presurgical knee function and mental health were correlated with symptomatic PTOA at 7 years, that there were specific anatomical factors associated with poor outcomes, and that there were no changes in outcomes due to tunnel widening in patients receiving hamstring tendon autografts. We also validated a magnetic resonance imaging technique to noninvasively assess graft strength. In conclusion, the RCT determined that initial graft tensioning does not have a major influence on 7-year outcomes. Therefore, surgeons can reconstruct the ACL using a graft tensioning protocol that is within the window of the two graft tensioning techniques evaluated in this RCT.
© 2020 Orthopaedic Research Society. Published by Wiley Periodicals LLC.

Entities:  

Keywords:  ACL; osteoarthritis; outcomes; reconstruction

Mesh:

Year:  2020        PMID: 32639610      PMCID: PMC7790866          DOI: 10.1002/jor.24794

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.102


  45 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

2.  Geometric profile of the tibial plateau cartilage surface is associated with the risk of non-contact anterior cruciate ligament injury.

Authors:  Bruce D Beynnon; Pamela M Vacek; Daniel R Sturnick; Leigh Ann Holterman; Mack Gardner-Morse; Timothy W Tourville; Helen C Smith; James R Slauterbeck; Robert J Johnson; Sandra J Shultz
Journal:  J Orthop Res       Date:  2013-09-30       Impact factor: 3.494

3.  Hop tests correlate with IKDC and KOOS at minimum of 2 years after primary ACL reconstruction.

Authors:  Emily K Reinke; Kurt P Spindler; Dawn Lorring; Morgan H Jones; Leah Schmitz; David C Flanigan; Angel Qi An; Amanda R Quiram; Emily Preston; Michael Martin; Bettina Schroeder; Richard D Parker; Christopher C Kaeding; Lynn Borzi; Angela Pedroza; Laura J Huston; Frank E Harrell; Warren R Dunn
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-03-29       Impact factor: 4.342

4.  Tibiofemoral centroid velocity correlates more consistently with cartilage damage than does contact path length in two ovine models of stifle injury.

Authors:  Jillian E Beveridge; Bryan J Heard; Nigel G Shrive; Cyril B Frank
Journal:  J Orthop Res       Date:  2013-07-06       Impact factor: 3.494

5.  Effect of Matching or Overconstraining Knee Laxity During Anterior Cruciate Ligament Reconstruction on Knee Osteoarthritis and Clinical Outcomes: A Randomized Controlled Trial With 84-Month Follow-up.

Authors:  Matthew R Akelman; Paul D Fadale; Michael J Hulstyn; Robert M Shalvoy; Arlene Garcia; Kaitlyn E Chin; Jeffrey Duryea; Gary J Badger; Glenn A Tung; Braden C Fleming
Journal:  Am J Sports Med       Date:  2016-04-19       Impact factor: 6.202

6.  MRI volume and signal intensity of ACL graft predict clinical, functional, and patient-oriented outcome measures after ACL reconstruction.

Authors:  Alison M Biercevicz; Matthew R Akelman; Paul D Fadale; Michael J Hulstyn; Robert M Shalvoy; Gary J Badger; Glenn A Tung; Heidi L Oksendahl; Braden C Fleming
Journal:  Am J Sports Med       Date:  2014-12-24       Impact factor: 6.202

7.  In Situ, noninvasive, T2*-weighted MRI-derived parameters predict ex vivo structural properties of an anterior cruciate ligament reconstruction or bioenhanced primary repair in a porcine model.

Authors:  Alison M Biercevicz; Daniel L Miranda; Jason T Machan; Martha M Murray; Braden C Fleming
Journal:  Am J Sports Med       Date:  2013-01-24       Impact factor: 6.202

8.  Tunnel widening following anterior cruciate ligament reconstruction using hamstring autograft: a comparison between double cross-pin and suspensory graft fixation.

Authors:  Joshua A Baumfeld; David R Diduch; L Joseph Rubino; Jennifer A Hart; Mark D Miller; Michelle S Barr; Joseph M Hart
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-09-13       Impact factor: 4.342

9.  Kinematic differences between optical motion capture and biplanar videoradiography during a jump-cut maneuver.

Authors:  Daniel L Miranda; Michael J Rainbow; Joseph J Crisco; Braden C Fleming
Journal:  J Biomech       Date:  2012-10-22       Impact factor: 2.712

10.  Impact of type of meniscal tear on radiographic and symptomatic knee osteoarthritis: a sixteen-year followup of meniscectomy with matched controls.

Authors:  M Englund; E M Roos; L S Lohmander
Journal:  Arthritis Rheum       Date:  2003-08
View more
  1 in total

1.  Wavelet analysis reveals differential lower limb muscle activity patterns long after anterior cruciate ligament reconstruction.

Authors:  Payam Zandiyeh; Lauren R Parola; Braden C Fleming; Jillian E Beveridge
Journal:  J Biomech       Date:  2022-01-20       Impact factor: 2.712

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.